Evidence map›Paper›PMID 28130004›Full record

Trial reportSchizophrenia research2017

The effects of oxytocin and galantamine on objectively-defined vocal and facial expression: Data from the CIDAR study.

Alex S Cohen, Kyle R Mitchell, Gregory P Strauss, Jack J Blanchard, Robert W Buchanan, Deanna L Kelly, James Gold, Robert P McMahon, Heather A Adams, William T Carpenter

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Schizophrenia research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Using biobehavioral technologies to effectively advance research on negative symptoms.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alex S CohenLouisiana State University, Department of Psychology, USA. Electronic address: acohen@lsu.edu.
Kyle R MitchellLouisiana State University, Department of Psychology, USA.
Gregory P StraussBinghamton University, Department of Psychology, USA.
Jack J BlanchardUniversity of Maryland, College Park, Department of Psychology, USA.
Robert W BuchananUniversity of Maryland School of Medicine, Maryland Psychiatric Research Center, USA.
Deanna L KellyUniversity of Maryland School of Medicine, Maryland Psychiatric Research Center, USA.
James GoldUniversity of Maryland School of Medicine, Maryland Psychiatric Research Center, USA.
Robert P McMahonUniversity of Maryland School of Medicine, Maryland Psychiatric Research Center, USA.
Heather A AdamsUniversity of Maryland School of Medicine, Maryland Psychiatric Research Center, USA.
William T CarpenterUniversity of Maryland School of Medicine, Maryland Psychiatric Research Center, USA.

Funding

Tretment of negative symptoms and cognitive impairment in schizopreniaP50MH082999 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI CARPENTER, WILLIAM T. · 2008 to 2012
$9.7M
NIMH NIH HHS P50 MH082999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Schizophrenic PsychologyAdultAntipsychotic AgentsFacial ExpressionGalantamineHumansInterpersonal RelationsInterview, PsychologicalMiddle AgedNeuropsychological TestsOxytocinPsychotic DisordersSchizophreniaSocial BehaviorSpeech Production MeasurementTreatment OutcomeAntipsychotic AgentsGalantamineOxytocinAcousticComputerGalantamineNegativeOxytocinProsodySchizophrenia

Identifiers

PMID28130004
PMCPMC5524598

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.